NAUT
NASDAQ · Life Sciences Tools & Services
Nautilus Biotechnology Inc
$1.87
+0.08 (+4.47%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,320.3% upside
Low Target
$24.26
Average Target
$26.56
High Target
$41.87
Current Price
$1.87
Current
$1.87
$1.87
Target
$26.56
$26.56
$24.26
$26.56 avg
$41.87
Scenario Analysis
Bear Case
$24.26
1,197.3%
Low target
Base Case
$26.56
+1,320.3%
Avg target
Bull Case
$41.87
+2,139.0%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$4.31
-56.6% from high
52-Week Low
$0.62
+201.6% from low
Target vs 52W High
$26.56
+516.2% vs high
Peer Consensus — Life Sciences Tools & Services
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| TMO | Strong Buy | 34 | 85% | $369.21 | -29.5% |
| DHR | Strong Buy | 30 | 90% | $158.11 | -20.1% |
| WAT | Buy | 28 | 57% | $189.60 | -50.0% |
| A | Strong Buy | 28 | 79% | $64.69 | -50.5% |
| IQV | Strong Buy | 30 | 80% | $82.96 | -59.9% |
| ILMN | Buy | 28 | 61% | $169.36 | -10.2% |
| MTD | Hold | 20 | 50% | $170.43 | -87.0% |
| WST | Strong Buy | 22 | 82% | $136.24 | -62.7% |